CSANZ Logo
CSANZ Logo
Welcome to the official website of the


CSANZ Logo
CSANZ Logo
Cardiac Society of Australia and New Zealand
CSANZ Logo


CSANZ Logo


CSANZ Logo

contact
links
want to join?
register
search the CSANZ website
search the CSANZ website
     







search the CSANZ website













CSANZ Directory

CSANZ Member Directory

CSANZ Guidelines

Practice Guidelines

Training and Competence

Meetings

What's On and Where

ASM Abstracts Online

News and Views

Newsletter - On the Pulse

Newsletter - CNWG

In the News

Affiliate News
Career Opportunities

Affiliate Member Area

Affiliate Calendar

Affiliate Discussion

Scholarships/ Fellowships

Working Groups


ASM Abstracts

B-TYPE NATRIURETIC PEPTIDE (BNP), BUT NOT ATRIAL NATRIURETIC PEPTIDE (ANP), IMPROVES HAEMODYNAMICS IN ACUTE HEART FAILURE.

R.L. Woods*#, H.P. Brunner-La Rocca, D.M. Kaye and M.D. Esler.

Baker Medical Research Institute, Prahran, and #Howard Florey Institute, University of Melbourne, 3010, Australia.

Experimental acute heart failure (AHF), induced by rapid cardiac pacing, causes inadequate cardiac pump function and hemodynamic consequences similar to that seen in humans after myocardial infarction.  Increased atrial pressures in AHF result in substantial release of atrial natriuretic peptide (ANP), but minimal changes in B-type natriuretic peptide (BNP).  Could there be a difference in responsiveness to ANP and BNP in the acute condition?  We investigated this possibility by infusing equimolar doses of ANP and BNP (10 pmol/kg per min) into anaesthetised dogs (n = 8) with AHF induced by rapid right ventricular pacing (193 ± 4 bpm) to increase pulmonary capillary wedge pressure (PCWP) to ~ 15mmHg.  After haemodynamics had stabilised (~ 45 min), randomised infusions of ANP or BNP, or sodium nitroprusside (SNP, 0.5 mg/kg per min) for comparison, were administered for 30min. Acute pacing reduced (P<0.05) cardiac output (CO; from 4.1 ± 0.4 to 2.5 ± 0.2 l/min) and arterial pressure (from 86.1 ± 2.4 to 74.5 ± 2.1mmHg), and raised (P<0.05) PCWP (from 6.6 ± 0.7 to 15.7 ± 0.3 mmHg), right atrial pressure (RAP; from 1.9 ± 0.5 to 4.0 ± 0.6 mmHg) and systemic vascular resistance (SVR; from 23.4 ± 2.6 to 29.1 ± 2.3 mmHg/l.min-1).  Infusions of BNP and SNP, respectively, improved CO (+13 ± 3 % & +9 ± 5 %) by reducing pre-load (PCWP -12 ± 2 % & -12 ± 2 % and RAP -28 ± 9 % & ‑-34 ± 6 %) and after-load (SVR -15 ± 4 % & -11 ± 3 %) (all p<0.01, except CO with SNP, ns).  By contrast, ANP did not significantly affect cardiac or peripheral haemodynamics. The ineffectiveness of ANP in AHF may result from a rapid desensitisation of the natriuretic peptide type A receptor, at high levels of ANP in vivo.  We propose that the marked haemodynamic differences between exogenous BNP and ANP may be due to a BNP-selective receptor that is yet to be identified.

[ Back to 48th ASM Abstract Index ]


Med-E-Serv